Brachytherapy
Volume 8, Issue 4 , Pages 345-352 , October 2009

Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study

  • Paul L. Nguyen

      Affiliations

    • Harvard Radiation Oncology Program, Boston, MA
    • Harvard Medical School, Boston, MA
    • Corresponding Author InformationCorresponding author. Harvard Radiation Oncology Program, 75 Francis Street, Boston, MA 02115. Tel.: +1-617-732-6310; fax: +1-617-732-7347.
  • ,
  • Ronald C. Chen

      Affiliations

    • Harvard Radiation Oncology Program, Boston, MA
    • Harvard Medical School, Boston, MA
  • ,
  • Jack A. Clark

      Affiliations

    • Department of Health Policy and Management, Boston University School of Public Health, Boston, MA
    • Center for Health Quality, Outcomes, and Economic Research, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
  • ,
  • Robert A. Cormack

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA
    • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA
    • Harvard Medical School, Boston, MA
  • ,
  • Marian Loffredo

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA
    • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA
    • Harvard Medical School, Boston, MA
  • ,
  • Elizabeth McMahon

      Affiliations

    • Harvard Medical School, Boston, MA
  • ,
  • Angela U. Nguyen

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA
    • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA
    • Harvard Medical School, Boston, MA
  • ,
  • W. Warren Suh

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA
    • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA
    • Harvard Medical School, Boston, MA
  • ,
  • Clare M. Tempany

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital, Boston, MA
    • Harvard Medical School, Boston, MA
  • ,
  • Anthony V. D'Amico

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA
    • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA
    • Harvard Medical School, Boston, MA

Received 20 October 2008 ,Revised 16 January 2009 ,Accepted 19 January 2009.

References 

  1. Nguyen PL, D'Amico AV, Lee AK, et al. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: A systematic review of the literature. Cancer. 2007;110:1417–1428
  2. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis. JAMA. 1999;281:1598–1604
  3. Zelefsky MJ, Kuban DA, Levy LB, et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys. 2007;67:327–333
  4. Izawa JI, Madsen LT, Scott SM, et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: Variables affecting patient outcome. J Clin Oncol. 2002;20:2664–2671
  5. Ward JF, Sebo TJ, Blute ML, et al. Salvage surgery for radiorecurrent prostate cancer: Contemporary outcomes. J Urol. 2005;173:1156–1160
  6. Grado GL, Collins JM, Kriegshauser JS, et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology. 1999;53:2–10
  7. Clark JA, Talcott JA. Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care. 2001;39:1118–1130
  8. Nguyen PL, Chen MH, D'Amico AV, et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: A prospective phase 2 study. Cancer. 2007;110:1485–1492
  9. ASTRO . Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997;37:1035–1041
  10. D'Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1998;42:507–515
  11. Nath R, Anderson LL, Luxton G, et al. Dosimetry of Interstitial Brachytherapy Sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys. 1995;22:209–234
  12. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261
  13. Indelicato DJ, Meadows K, Gibbs CP, et al. Effectiveness and morbidity associated with reirradiation in conservative salvage management of recurrent soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2009;73:267–272
  14. Kasperts N, Slotman B, Leemans CR, et al. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol. 2005;41:225–243
  15. Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:67–74
  16. Zietman AL. Correction: Inaccurate analysis and results in a study of radiation therapy in adenocarcinoma of the prostate. JAMA. 2008;299:898–899
  17. D'Amico AV, Tempany CM, Schultz D, et al. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology. 2003;62:1063–1067

PII: S1538-4721(09)00199-8

doi: 10.1016/j.brachy.2009.01.004

Brachytherapy
Volume 8, Issue 4 , Pages 345-352 , October 2009